Eqitx to raise $1.8 million
By Melissa Trudinger
Tuesday, 07 December, 2004
Tuesday, 07 December, 2004
Melbourne-based biotech managed investment group EQiTX (ASX: EQX) will ask shareholders to approve a AUD$1.8 million capital raising to provide working capital for its two projects ZingoTX and VacTX.
The placement, involving the issue of six million new shares at $0.30 plus two million free attaching options with an exercise price of $0.20, is to be underwritten by Cunningham Securities.
Related News
mRNA successfully delivered through blood–brain barrier
Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic...
Biological computer could revolutionise medical sciences
The CL1 is a commercial biological computer which fuses lab-cultivated neurons from human stem...
Genetic risk of schizophrenia impacts men and women differently
Men tend to present different clinical symptoms from women, poorer premorbid functioning and...
